Miller TP - Search Results

1

Tumor-infiltrating T-lymphocytes in B-cell diffuse large cell lymphoma related to disease course.

Lippman SM, Spier CM, Miller TP, Slymen DJ, Rybski JA, Grogan TM. Lippman SM, et al. Among authors: miller tp. Mod Pathol. 1990 May;3(3):361-7. Mod Pathol. 1990. PMID: 2194216

2

The aberrancy of immunophenotype and immunoglobulin status as indicators of prognosis in B cell diffuse large cell lymphoma.

Spier CM, Grogan TM, Lippman SM, Slymen DJ, Rybski JA, Miller TP. Spier CM, et al. Among authors: miller tp. Am J Pathol. 1988 Oct;133(1):118-26. Am J Pathol. 1988. PMID: 3140668 Free PMC article.

3

Lennert's lymphoma. A clinicopathologic study with emphasis on phenotype and its relationship to survival.

Spier CM, Lippman SM, Miller TP, Grogan TM. Spier CM, et al. Among authors: miller tp. Cancer. 1988 Feb 1;61(3):517-24. doi: 10.1002/1097-0142(19880201)61:3<517::aid-cncr2820610317>3.0.co;2-1. Cancer. 1988. PMID: 3257404

4

The prognostic significance of the immunotype in diffuse large-cell lymphoma: a comparative study of the T-cell and B-cell phenotype.

Lippman SM, Miller TP, Spier CM, Slymen DJ, Grogan TM. Lippman SM, et al. Among authors: miller tp. Blood. 1988 Aug;72(2):436-41. Blood. 1988. PMID: 3261181 Free article.

5

Independent prognostic significance of a nuclear proliferation antigen in diffuse large cell lymphomas as determined by the monoclonal antibody Ki-67.

Grogan TM, Lippman SM, Spier CM, Slymen DJ, Rybski JA, Rangel CS, Richter LC, Miller TP. Grogan TM, et al. Among authors: miller tp. Blood. 1988 Apr;71(4):1157-60. Blood. 1988. PMID: 3281723 Free article.

6

HLA-DR (Ia) immune phenotype predicts outcome for patients with diffuse large cell lymphoma.

Miller TP, Lippman SM, Spier CM, Slymen DJ, Grogan TM. Miller TP, et al. J Clin Invest. 1988 Jul;82(1):370-2. doi: 10.1172/JCI113598. J Clin Invest. 1988. PMID: 3392214 Free PMC article.

7

Deficient tumor-infiltrating T-lymphocyte response in malignant lymphoma: relationship to HLA expression and host immunocompetence.

List AF, Spier CM, Miller TP, Grogan TM. List AF, et al. Among authors: miller tp. Leukemia. 1993 Mar;7(3):398-403. Leukemia. 1993. PMID: 7680400

8

Prognostic significance of the Ki-67-associated proliferative antigen in aggressive non-Hodgkin's lymphomas: a prospective Southwest Oncology Group trial.

Miller TP, Grogan TM, Dahlberg S, Spier CM, Braziel RM, Banks PM, Foucar K, Kjeldsberg CR, Levy N, Nathwani BN, et al. Miller TP, et al. Blood. 1994 Mar 15;83(6):1460-6. Blood. 1994. PMID: 8123837 Free article. Clinical Trial.

9

Prediction of Outcome in Diffuse Large Cell Lymphoma by the Major Histocompatibility Complex Class II (HLA-DR, DP, DQ) and Class I (HLA-A, B, C) Phenotype.

Rybski JA, Spier CM, Miller TP, Lippman SM, McGee DL, Grogan TM. Rybski JA, et al. Among authors: miller tp. Leuk Lymphoma. 1991;6(1):31-8. doi: 10.3109/10428199109064876. Leuk Lymphoma. 1991. PMID: 27457573

10

Neural cell adhesion molecule-positive peripheral T-cell lymphoma: a rare variant with a propensity for unusual sites of involvement.

Kern WF, Spier CM, Hanneman EH, Miller TP, Matzner M, Grogan TM. Kern WF, et al. Among authors: miller tp. Blood. 1992 May 1;79(9):2432-7. Blood. 1992. PMID: 1373974 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

255 results

Search Page

Filters